Narmadha Selvaraj 1 , Kalaivani Subramaniam
BACKGROUND The incidence and morbidity of bacterial vaginosis is high. But most of the patients are asymptomatic and recurrences are common even after effective treatment. Studies comparing the therapeutic efficacy of the drugs indicated for Bacterial vaginosis are also very minimal. Aim of this study was to analyse the epidemiological pattern of bacterial vaginosis and to compare the efficacy of Metronidazole and Lactobacillus in the management of bacterial vaginosis. MATERIALS AND METHODS 100 newly diagnosed Bacterial vaginosis patients were enrolled and randomly allotted into two study groups of Metronidazole for one week and Lactobacillus for two months respectively. The patients are followed up based on Amsel’s criteria and Nugent’s scoring system at the time of initiation of treatment, one week, one month, two months and six months after treatment. Ultrasonogram was done at the end of two months. Statistical Analysis- chi square test with yate’s correction and Fisher’s exact test (2 tailed) to calculate the P value. Settings and Design- Prospective, open labeled, comparative clinical trial. RESULTS Lactobacillus group was better than Metronidazole based on Amsel’s criteria at six months follow up period and based on Nugent’s scoring system at two months and six months follow up period. CONCLUSION Epidemiological interpretation in our study shows Bacterial vaginosis is common in the 24-40 years of age; marital status, earlier age at marriage, number of deliveries is directly proportionate to bacterial vaginosis incidence. Irregular menstrual cycle, number of sexual partners, and mode of delivery has no association with the incidence of Bacterial vaginosis. Moderate to profuse genital discharge is the commonest symptom observed. Whiff test (80%), Clue cells (90%) and alkaline vaginal pH > 5 has high degree of sensitivity
